PDH-E1α inhibitors belong to a significant class of compounds within the realm of enzymology and biochemistry. These inhibitors specifically target the enzyme Pyruvate Dehydrogenase Complex E1α (PDH-E1α), a crucial component of the pyruvate dehydrogenase complex located within the mitochondria of cells. The pyruvate dehydrogenase complex plays a pivotal role in the metabolic process known as aerobic respiration, which facilitates the conversion of pyruvate, a product of glycolysis, into acetyl-CoA. This conversion is a key step linking glycolysis and the citric acid cycle, thereby providing a vital bridge between the breakdown of glucose and the production of cellular energy in the form of adenosine triphosphate (ATP). PDH-E1α inhibitors act by impeding the activity of the PDH-E1α enzyme, which catalyzes the decarboxylation of pyruvate and its subsequent transformation into acetyl-CoA. By modulating the function of this enzyme, PDH-E1α inhibitors can exert significant influence over cellular energy production and metabolic pathways. These inhibitors often interact with specific regions of the PDH-E1α enzyme, disrupting its active site and hampering its ability to bind pyruvate and carry out the catalytic reaction. This disruption effectively curtails the conversion of pyruvate to acetyl-CoA, which in turn can lead to alterations in downstream processes such as the citric acid cycle and oxidative phosphorylation. The inhibition of PDH-E1α can have far-reaching consequences for cellular energy metabolism and is relevant in various physiological and pathological contexts.
In summary, PDH-E1α inhibitors constitute a distinctive class of compounds that play a vital role in regulating the metabolic conversion of pyruvate to acetyl-CoA. Through their targeted interference with the PDH-E1α enzyme, these inhibitors influence the intricate network of cellular energy production and metabolic pathways, underscoring their significance in biochemical research and offering avenues for the modulation of metabolic processes in various biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium dichloroacetate | 2156-56-1 | sc-203275 sc-203275A | 10 g 50 g | $55.00 $209.00 | 6 | |
Inhibits PDH-E1α by activating PDKs, reducing pyruvate conversion. | ||||||
CPI-613 | 95809-78-2 | sc-482709 | 10 mg | $131.00 | 4 | |
Alters PDH complex through multiple mechanisms, disrupting activity. | ||||||
UK 5099 | 56396-35-1 | sc-361394 sc-361394A | 10 mg 50 mg | $236.00 $987.00 | 5 | |
Selectively inhibits PDH-mediated pyruvate transport into mitochondria. | ||||||
Citric Acid, Anhydrous | 77-92-9 | sc-211113 sc-211113A sc-211113B sc-211113C sc-211113D | 500 g 1 kg 5 kg 10 kg 25 kg | $50.00 $110.00 $145.00 $248.00 $598.00 | 1 | |
Allosterically inhibits PDH-E1α by binding to an inhibitory site. | ||||||
Radicicol | 12772-57-5 | sc-200620 sc-200620A | 1 mg 5 mg | $92.00 $333.00 | 13 | |
Binds to Hsp90, indirectly leading to PDH-E1α inhibition. | ||||||
LGK 974 | 1243244-14-5 | sc-489380 sc-489380A | 5 mg 50 mg | $359.00 $1295.00 | 2 | |
Inhibits Wnt signaling pathway, impacting PDH-E1α indirectly. | ||||||